acetylcysteine has been researched along with Pneumoperitoneum in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Poli de Figueiredo, LF; Seguro, AC; Shimizu, MH | 1 |
Shebrain, S | 1 |
2 other study(ies) available for acetylcysteine and Pneumoperitoneum
Article | Year |
---|---|
N-acetylcysteine (NAC) protects against acute kidney injury (AKI) following prolonged pneumoperitoneum in the rat.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Antioxidants; Carbon Dioxide; Glomerular Filtration Rate; Infusions, Parenteral; Inulin; Kidney; Male; Models, Animal; Oxidative Stress; Pneumoperitoneum; Rats; Rats, Wistar; Reperfusion Injury; Thiobarbituric Acid Reactive Substances; Time Factors | 2012 |
Commentary on "N-acetylcysteine (NAC) protects against acute kidney injury following prolonged pneumoperitoneum".
Topics: Acetylcysteine; Acute Kidney Injury; Humans; Pneumoperitoneum; Protective Agents | 2011 |